Kratom exposures reported to texas poison centers

Journal of Addictive Diseases

Volumn 32, Issue 4, 2013, Pages 396-400

  Forrester, Mathias B ^a  

^a TEXAS DEPARTMENT OF STATE HEALTH SERVICES   (United States)

Author keywords

Kratom; poison center

Indexed keywords

ANTIEMETIC AGENT; ANTIHYPERTENSIVE AGENT; BENZODIAZEPINE DERIVATIVE; CREATINE KINASE; INFUSION FLUID; OXYGEN;

ABDOMINAL PAIN; AGITATION; ARTICLE; BRADYCARDIA; CONFUSION; CREATINE KINASE BLOOD LEVEL; DIAPHORESIS; DROWSINESS; DYSPNEA; EXPOSURE; HALLUCINATION; HEALTH CARE FACILITY; HUMAN; HYPERTENSION; HYPERVENTILATION; KRATOM; MITRAGYNA; MYDRIASIS; NAUSEA; POISON CENTER; SEDATION; SLURRED SPEECH; TACHYCARDIA; TREMOR; UNITED STATES; VOMITING;

ADOLESCENT; ADULT; DATABASES AS TOPIC; FEMALE; HUMANS; MALE; MIDDLE AGED; MITRAGYNA; POISON CONTROL CENTERS; PSYCHOTROPIC DRUGS; RETROSPECTIVE STUDIES; SECOLOGANIN TRYPTAMINE ALKALOIDS; SUBSTANCE-RELATED DISORDERS; TEXAS; UNITED STATES; YOUNG ADULT;

EID: 84890488787     PISSN: 10550887     EISSN: 15450848     Source Type: Journal    
DOI: 10.1080/10550887.2013.854153     Document Type: Article

References (33)

1. Drug Enforcement Administration. Kratom (Mitragyna speciosa korth). (Street names: Thang, Kakuam, Thom, Ketum, Biak). Drug Enforcement Administration, January 2013. http://www.deadiversion.usdoj.gov/drug chem info/kratom.pdf (accessed February 23, 2013).
2. DiSalvo D. Is kratom the new "Bath Salts" or just an organic pain reliever with euphoric effects? Forbes, September 22, 2012. http://www.forbes.com/sites/davidd isalvo/2012/09/22/is-kratom-the-new-bath- salts-or-just-an-organic-pain-reliever-with-euphoric-effects/(accessed February 24, 2013).
3. Shellard EJ. Ethnopharmacology of kratom and the Mitragyna alkaloids. J Ethnopharmacol 1989; 25:123-4.
4. Vicknasingam B, Narayanan S, Beng GT, Mansor SM. The informal use of ketum (Mitragyna speciosa) for opioid withdrawal in the northern states of peninsular Malaysia and implications for drug substitution therapy. Int J Drug Policy 2010; 21:283-8. doi: 10.1016/j.drugpo.2009.12.003.
5. Hassan Z, Muzaimi M, Navaratnam V, et al. From Kratom to mitragynine and its derivatives: physiological and behavioural effects related to use, abuse, and addiction. Neurosci Biobehav Rev 2013; 37: 138-51. doi: 10.1016/j.neubiorev. 2012. 11.012.
6. Ulbricht C, Costa D, Dao J, et al. An evidence-based systematic review of kratom (Mitragyna speciosa) by the Natural Standard Research Collaboration. J Diet Suppl 2013; 10:152-70. doi: 10.3109/19390211.2013.793541
7. Rosenbaum CD, Carreiro SP, Babu KM. Here today, gone tomorrow. and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazines. J Med Toxicol 2012; 8:15-32. doi: 10.1007/s13181-011-0202-2.
8. Babu KM, McCurdy CR, Boyer EW. Opioid receptors and legal highs: Salvia divinorum and kratom. Clin Toxicol (Phila) 2008; 46:146-52. doi: 10.1080/15563650701241795.
9. Thongpradichote S, Matsumoto K, Tohda M, et al. Identification of opioid receptor subtypes in antinociceptive actions of supraspinally-administered mitragynine in mice. Life Sci 1998; 62:1371-8.
10. Yamamoto LT, Horie S, Takayama H, et al. Opioid receptor agonistic characteristics of mitragynine pseudoindoxyl in comparison with mitragynine derived from Thai medicinal plant Mitragyna speciosa. Gen Pharmacol 1999; 33:73-81.
11. Shellard E. The alkaloids of Mitragyna with special reference to those of Mitragyna speciosa, Korth. Bull Narc 1974; 26:41-55.
12. Matsumoto K, Mizowaki M, Suchitra T, et al. Antinociceptive action of mitragynine in mice: evidence for the involvement of supraspinal opioid receptors. Life Sci 1996; 59:1149-55.
13. Matsumoto K, Mizowaki M, Suchitra T, et al. Central antinociceptive effects of mitragynine in mice: contribution of descending noradrenergic and serotonergic systems. Eur J Pharmacol 1996; 317: 75-81.
14. Matsumoto K, Yamamoto LT, Watanabe K, et al. Inhibitory effect of mitragynine, an analgesic alkaloid from Thai herbal medicine, on neurogenic contraction of the vas deferens. Life Sci 2005; 78:187-94.
15. Matsumoto K, Horie S, Takayama H, et al. Antinociception, tolerance and withdrawal symptoms induced by 7-hydroxymitragynine, an alkaloid from the Thai medicinal herb Mitragyna speciosa. Life Sci 2005; 78:2-7.
16. Suwanlert S. A study of kratom eaters in Thailand. Bull Narc 1975; 27:21-7.
17. Kronstrand R, Roman M, Thelander G, Eriksson A. Unintentional fatal intoxications with mitragynine and Odesmethyltramadol from the herbal blend Krypton. J Anal Toxicol 2011; 35:242-7.
18. Wolfson S. New warning about kratom use. KXAN, August 11, 2012. http://www.kxan. com/dpp/news/local/austin/new-warningabout-kratom-use (accessed February 24, 2013).
19. Maruyama T, Kawamura M, Kikura-Hanajiri R, Takayama H Goda Y. The botanical origin of Kratom (Mitragyna speciosa; Rubiaceae) available as abused drugs in the Japanese markets. J Nat Med 2009; 63:340-4. doi: 10.1007/s11418-009-0325-9.
20. Jansen KL, Prast CJ. Psychoactive properties of mitragynine (kratom). J Psychoactive Drugs 1988; 20:455-7.
21. Ingalls C. 'Kratom' craze worries federal drug agency. King 5 News, January 14, 2013. http://www.king5.com/news/investi gators/The-new-drug-you- havent-heard-of-yet-186851112.html (accessed February 24, 2013).
22. Huus K. Asian leaf 'kratom' making presence felt in US emergency rooms. NBC News, March 19, 2012. http://usnews.nb cnews.com/news/2012/03/19/10760892- asian-leaf-kratom-making-presence-felt-in-us-emergency-rooms?lite (accessed February 24, 2013).
23. Nelsen JL, Lapoint J, Hodgman MJ, Aldous KM. Seizure and coma following Kratom (Mitragynina speciosa Korth) exposure. J Med Toxicol 2010; 6:424-6. doi: 10.1007/s13181-010-0079-5.
24. Trakulsrichai S. Kratom abuse in Ramathibodi Poison Center: a 5-year study. Asia Pacific Association of Medical Toxicology 9th Congress Meeting, November 18, 2010. http://www.asiatox.org/9th%20apa mt/OP/KRATOM%20ABUSE%20IN%20 RAMATHIBODI%20POISON%20CENTER % 20A5 % 20YEAR % 20EXPERIENCE. pdf (accessed February 24, 2013).
25. Roche KM, Hart K, Sangalli B, Lefberg J, Bayer M. Kratom: a case of a legal high. Clin Toxicol (Phila) 2008; 46:598.
26. Neerman MF, Frost RE, Deking J. A drug fatality involving Kratom. J Forensic Sci 2013; 58:S278-9. doi: 10.1111/1556-4029.12009.
27. Holler JM, Vorce SP, McDonough-Bender PC, Magluilo J Jr, Solomon CJ, Levine B. A drug toxicity death involving propylhexedrine and mitragynine. J Anal Toxicol 2011; 35:54-9.
28. Le D, Goggin MM, Janis GC. Analysis of mitragynine and metabolites in human urine for detecting the use of the psychoactive plant kratom. J Anal Toxicol 2012; 36:616-25. doi: 10.1093/jat/bks073.
29. Wolfson S. New warning about kratom use. KXAN, August 11, 2012. http://www.kxan. com/dpp/news/local/austin/newwarning-about-kratom-use (accessed February 24, 2013).
30. Sheleg SV, Collins GB. A coincidence of addiction to "Kratom" and severe primary hypothyroidism. J Addict Med 2011; 5:300-1.
31. Boyer EW, Babu KM, Adkins JE, Mc-Curdy CR, Halpern JH. Self-treatment of opioid withdrawal using kratom (Mitragynia speciosa korth). Addiction 2008; 103:1048-50.
32. Bronstein AC, Spyker DA, Cantilena LR, Rumack BH, Dart RC. 2011 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 29th Annual Report. Clin Toxicol (Phila) 2012; 50:911-1164. doi: 10.3109/15563650.2012.746 424.
33. Nelson JL, Hodgman MJ, LaPoint J, Aldous KM. Seizure following kratom exposure. Clin Toxicol (Phila) 2009; 47: 760.